Former Johnson & Johnson Senior Executive Kristine Peterson to Take Helm
PARSIPPANY, N.J., June 1 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has hired Kristine Peterson to serve as its Chief Executive Officer.
Peterson brings 26 years of industry experience to Valeritas, with her most recent successes as Company Group Chair of Johnson & Johnson's Biotech Business where she was directly responsible for commercial, research & development and supply chain/manufacturing for biotech, oncology, immunology, and cell therapy.
"We are thrilled that Kris has joined the Valeritas executive team," said Vaughn Kailian, Executive Chairman of the Board, Valeritas, Inc and Managing Director of MPM Capital. "She exhibits a broad range of experience and leadership qualities, along with a deep compassion for patients and their challenges. This exceptional skill set makes her the ideal leader to take Valeritas to the next level as a fully operational medical technology company."
"Joining Valeritas at this pivotal time in its lifecycle is a great privilege," said Peterson. "With the company's strong financial backing, a potentially life changing first product, and a broad technology platform that can support a wide array of therapeutic options, Valeritas is positioned to be a highly successful company."
Peterson joined Johnson & Johnson in August 2004 as Executive Vice President, Pharmaceutical Group Strategic Marketing with responsibility for developing global launch plans for Internal Medicine, Metabolics, Central Nervous System, Oncology, Virology, Anemia and Pain franchises. Prior to joining J&J, Peterson was Senior Vice President, Commercial Operations, Biovail Corporation and President Biovail Pharmaceuticals. In this role, she was resp
|SOURCE Valeritas, Inc.|
Copyright©2009 PR Newswire.
All rights reserved